Charming Medical Limited (MCTA)

Charming Medical Income Statement

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Revenue	5.42	6.22	6.02	3.53
Revenue Growth (YoY)	-14.36%	3.43%	70.37%	-
Cost of Revenue	0.04	0.02	0.01	0.02
Gross Profit	5.38	6.21	6	3.51
Selling, General & Admin	4.41	4.55	4.6	3.82
Depreciation & Amortization Expenses	0.23	0.26	0.39	0.21
Total Operating Expenses	4.64	4.82	5	4.03
Operating Income	0.74	1.39	1.01	-0.52
Interest Income	0.05	0.06	0.02	0.01
Interest Expense	-0.02	-0.02	-0.03	-0.02
Other Non-Operating Income (Expense)	0.05	0	0	0.11
Total Non-Operating Income (Expense)	0.08	0.05	-0.01	0.1
Pretax Income	0.84	1.44	1	-0.42
Provision for Income Taxes	0.29	0.24	0.18	-0.08
Net Income	0.66	1.2	0.78	-0.31
Minority Interest in Earnings	-	-	0.04	-0.03
Net Income to Common	0.66	1.2	0.78	-0.31
Net Income Growth	62.92%	54.16%	-	-
Shares Outstanding (Basic)	15	15	15	15
Shares Outstanding (Diluted)	15	15	15	15
EPS (Basic)	0.05	0.08	0.05	-0.02
EPS (Diluted)	0.05	0.08	0.05	-0.02
EPS Growth	-16.67%	60.00%	-	-
Shares Outstanding	15.34	15.34	15.34	15.34
Free Cash Flow	0.4	0.14	0.08	1.83
Free Cash Flow Growth	190.01%	63.10%	-95.36%	-
Free Cash Flow Per Share	0.03	0.01	0.01	0.12
Gross Margin	99.27%	99.75%	99.81%	99.51%
Operating Margin	13.64%	22.32%	16.77%	-14.77%
Profit Margin	12.12%	19.27%	13.66%	-9.51%
FCF Margin	7.40%	2.22%	1.41%	51.76%
EBITDA	0.97	1.65	1.4	-0.31
EBITDA Margin	17.92%	26.56%	23.28%	-8.79%
EBIT	0.74	1.39	1.01	-0.52
EBIT Margin	13.64%	22.32%	16.77%	-14.77%
Effective Tax Rate	35.24%	16.45%	18.11%	20.18%

Updated Mar 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q